Results 11 to 20 of about 23,298 (210)
Abstract Human fibrinogen concentrate (Fibryga) received temporary approval for fibrinogen replacement therapy in France (2017), with subsequent full approval for congenital and acquired hypofibrinogenemia. We evaluated real‐world use for on‐demand treatment of bleeding and prophylaxis to enhance our knowledge on fibrinogen concentrate as an option for
Francois Stéphan +8 more
wiley +1 more source
Abstract Background and purpose Cerebral venous sinus thrombosis due to vaccine‐induced immune thrombotic thrombocytopenia (CVST‐VITT) is an adverse drug reaction occurring after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination.
Katarzyna Krzywicka +52 more
wiley +1 more source
We retrospectively analyzed data from 6537 predominantly hospitalized COVID‐19 patients registered in the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS) registry between January 2020 and February 2021. Common neurological symptoms were excessive tiredness (28.0%), headache (18.5%), nausea/emesis (16.6%), muscular ...
Nina N. Kleineberg +31 more
wiley +1 more source
Abstract Acute respiratory distress syndrome (ARDS) in COVID‐19 is associated with high mortality. Mesenchymal stem cells are known to exert immunomodulatory and anti‐inflammatory effects and could yield beneficial effects in COVID‐19 ARDS. The objective of this study was to determine safety and explore efficacy of umbilical cord mesenchymal stem cell (
Giacomo Lanzoni +30 more
wiley +1 more source
Liver diseases, including cirrhosis, viral hepatitis, and hepatocellular carcinoma, account for approximately two million annual deaths worldwide. They place a huge burden on the global healthcare systems, compelling researchers to find effective treatment for liver fibrosis‐cirrhosis.
Martín Muñoz-Ortega +8 more
wiley +1 more source
Present and future of low molecular weight heparin prophylaxis [PDF]
Peer ...
Kakkar, V. V.
core +2 more sources
Antecedentes: La trombosis venosa y el tromboembolismo venoso son complicaciones frecuentes en los pacientes durante su hospitalización, inclusive posterior a su egreso hospitalario.
Allan Robles Calderón +1 more
doaj +1 more source
Introducción: La reciente aparición de membranas de corte medio ofrece una alternativa para la eliminación de moléculas medianas y nueva terapia dialítica, la hemodiálisis expandida. Estas membranas se caracterizan por un mayor tamaño de poro que podría
Raquel Pelayo-Alonso +4 more
doaj +1 more source
TROMBOCITOPENIA INDUZIDA POR HEPARINA COMO CAUSA DE TROMBOEMBOLISMO PULMONAR: RELATO DE CASO
Objetivo: Relatar e discutir as abordagens diagnóstica e terapêutica de um caso de tromboembolismo pulmonar (TEP) por trombocitopenia induzida por heparina (HIT).
VG Freitas +9 more
doaj +1 more source
Este estudo foi delineado para desenvolver um modelo animal de hiperlipemia crônica, independente de manipulação dietética, visando análise da interação metabólica glicose/ácidos graxos livres (AGL) no exercício.
Maria Alice Rostom de Mello +2 more
doaj +1 more source

